The possible therapeutic effects of nicotine are mediated through the activation of the astrocyte nAChR; astrocyte calcium mobilization decreases pro-inflammatory cytokine release and increases astrocyte glial-derived neurotrophic factor synthesis, suggesting that nAChR expressed on astrocytes may be a better therapeutic target for the treatment of PD [162]. The gene discussed is CHRNA4; the disease is Parkinson disease.